Horizon Europe is the European Union (EU) funding programme for the period 2021 – 2027, which targets the sectors of research and innovation. The programme’s budget is around € 95.5 billion, of which € 5.4 billion is from NextGenerationEU to stimulate recovery and strengthen the EU’s resilience in the future, and € 4.5 billion is additional aid.
This Call focuses on the creation of a database of biomaterials, providing detailed information on the chemical-physical, biological and toxicological properties accessible to wide variety of end-users, for e.g. researchers, companies and clinicians for the purposes of evaluating the biological and clinical usefulness also in the areas beyond their intended primary applications. Processing of data should be done in accordance with GDPR provisions.
Projects will incorporate data on as many of the material properties as possible, allowing for the development of standardised protocols for the determination and measurement of the efficacy and safety of new biomaterials, taking into account the specificities due to sex, race and age, whether they be single or combination entities.
A label of biocompatibility should be established so as to define the suitability of a biomaterial for eventual use in a Medical Device or Advanced Therapy that the biomaterial becomes a part of, so as to assist companies, especially SMEs, in choosing and facilitating market access for their products.
Proposals must also address all the areas below:
100%
EU contribution per project: between €2,00 and €4,00 million
Research and Innovation Foundation
29a Andrea Michalakopoulou Street, 1075 Nicosia
T.Th. 23422, 1683 Nicosia
+357 22205000
Email: support@research.org.cy
Dr Angelos Ntantos
Scientific Officer
Telephone: 35722205033
Email: antantos@research.org.cy
Dr Ioannis Theodorou
Scientific Officer
Telephone: 35722205038
Email: itheodorou@research.org.cy
(Publish Date: 16/09/2021-for internal use only)
European Commission, Directorate-General for Research and Innovation
https://ec.europa.eu/info/departments/research-and-innovation_en#contact